/Companies

Sage Therapeutics

Cambridge, US · Founded 2010 · Delaware corporation · 2 known investors

Find your way into Sage Therapeutics

404 people in our graph share verified history with the Sage Therapeutics team — schools, employers, funds. One of them is your warm intro.

Doug Kerrunlockedknows Jeffrey M. Jonas · together at Generation Bio (overlapped)
×2knows the team · via Noema Pharma
×2knows the team · via Forest Laboratories
×7knows the team · via Cure Ventures

Founders & leadership

BGBarry Greene
Barry GreeneCEO
KI
Kimi IguchiChief Financial Officer2013–2024Kimi Iguchi is a financial executive with over 25 years of experience in biotechnology, having worked on capital raising, strategic partnerships, and financial operations across multiple companies from early-stage research through commercialization. He has served in board and audit committee roles focused on corporate governance and strategic oversight.
MC
Michael CloonanExecutive
AM
Anne Marie CookExecutive
SJ
Stephen J. KanesExecutive
JMJeffrey M. Jonas
Jeffrey M. JonasDirector2013–2023Partner at Cure Ventures
JM
Jeffery M. JonasExecutive
ARAlbert Robichaud
Albert RobichaudChief Scientific Officer2011–2023Partner at Cure Ventures
EB
Elizabeth BarrettNamed on SEC filing
JF
James FratesNamed on SEC filing
GG
Geno GermanoNamed on SEC filing
GG
George GolumbeskiNamed on SEC filing

Investors · 2

Reported raises · per SEC filings

Form D private placements

$698M disclosed across 3 rounds · 2014–2020

▶$650MraisedJan 2021 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Barry GreeneExecutive Officer, Director
  • Kimi IguchiExecutive Officer
  • Michael CloonanExecutive Officer
  • Anne Marie CookExecutive Officer
  • Stephen J. KanesExecutive Officer
  • Albert RobichaudExecutive Officer
  • Jeffrey M. JonasExecutive Officer, Director
  • Elizabeth BarrettDirector
  • James FratesDirector
  • Geno GermanoDirector
  • George GolumbeskiDirector
  • Steven PaulDirector
  • Kevin P. StarrDirector
  • Michael F. ColaDirector
Offering amount
$650M
Amount sold
$650M
First sale
Dec 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$38MraisedMar 2014 · 15 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven PaulDirector
  • Robert T. NelsenDirector
  • Kevin StarrDirector
  • Jeffery M. JonasExecutive Officer, Director
  • Kimi IguchiExecutive Officer
Offering amount
$38M
Amount sold
$38M
First sale
Mar 2014
Incorporated
Corporation, Delaware, 2010
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedJan 2014 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven PaulDirector
  • Kimi IguchiExecutive Officer
  • Jeffery M. JonasExecutive Officer, Director
  • Robert T. NelsenDirector
  • Kevin StarrDirector
Offering amount
$20M
Amount sold
$10M
First sale
Jan 2014
Incorporated
Corporation, Delaware, 2010
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

5 people who came through Sage Therapeutics went on to found or lead other companies.

Frequently asked questions

Who are Sage Therapeutics's investors?
Sage Therapeutics's investors include ARCH Venture Partners, Third Rock Ventures.
How much funding has Sage Therapeutics raised?
Sage Therapeutics has disclosed $698M raised across 3 rounds.
Where is Sage Therapeutics headquartered?
Sage Therapeutics is headquartered in Cambridge, US.